0001179110-18-013566.txt : 20181207
0001179110-18-013566.hdr.sgml : 20181207
20181207171509
ACCESSION NUMBER: 0001179110-18-013566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181204
FILED AS OF DATE: 20181207
DATE AS OF CHANGE: 20181207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schumacher Laura J
CENTRAL INDEX KEY: 0001319245
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35565
FILM NUMBER: 181224217
MAIL ADDRESS:
STREET 1: 1 N. WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbbVie Inc.
CENTRAL INDEX KEY: 0001551152
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320375147
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
BUSINESS PHONE: (847) 932-7900
MAIL ADDRESS:
STREET 1: 1 NORTH WAUKEGAN ROAD
CITY: NORTH CHICAGO
STATE: IL
ZIP: 60064
4
1
edgar.xml
FORM 4 -
X0306
4
2018-12-04
0
0001551152
AbbVie Inc.
ABBV
0001319245
Schumacher Laura J
1 N. WAUKEGAN ROAD
NORTH CHICAGO
IL
60064
0
1
0
0
Executive Vice President
Common stock, $0.01 par value
2018-12-04
4
M
0
94140
51.42
A
192398
D
Common stock, $0.01 par value
2018-12-04
4
S
0
33198
94.3418
D
159200
D
Common stock, $0.01 par value
2018-12-04
4
S
0
41642
93.6647
D
117558
D
Common stock, $0.01 par value
2018-12-04
4
S
0
10000
92.3705
D
107558
D
Common stock, $0.01 par value
2018-12-04
4
S
0
9300
91.7745
D
98258
D
Option (Right to buy)
51.42
2018-12-04
4
M
0
94140
0
D
2015-02-20
2024-02-19
Common Stock
94140
0
D
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.98 to $94.98, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.97, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.98 to $92.97, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.515 to $92.97, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
The transactions reported on this Form 4 were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).
Steven L. Scrogham, attorney-in-fact for Laura J. Schumacher
2018-12-07